MicrobiologybioRxivPreprint
The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2
C. Q. Sacramento, N. Fintelman-Rodrigues, J. R. Temerozo…·T. M. L. Souza
This study evaluates the antiviral activity of daclatasvir and sofosbuvir against SARS-CoV-2 in vitro, showing inhibition of viral replication and associated pathologies.
DOI 10.1101/2020.06.15.153411